101. 1346 THE RELATIONSHIP BETWEEN HEPATIC STEATOSIS IL28B AND RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C
- Author
-
John G. McHutchison, Josephine H. Li, Alexander J. Thompson, Hans L. Tillmann, Stephen D. Gardner, Jeanette J. McCarthy, Cynthia D. Guy, Paul J. Clark, Xiang Qian Lao, Kushang V. Patel, and Andrew J. Muir
- Subjects
medicine.medical_specialty ,education.field_of_study ,Hepatology ,business.industry ,Standard treatment ,Population ,medicine.disease ,Gastroenterology ,Oligonucleotide primers ,Chronic hepatitis ,Internal medicine ,Cohort ,medicine ,In patient ,Steatosis ,education ,business ,SNP array - Abstract
20 G2) were included. SVR was defined as undetectable HCVRNA at 24 weeks of follow up. The SNP analysis of rs12979860 variant was determined in 50ng of DNA by RT-PCR using specific oligonucleotide primers and probes to amplify the sequence target in DNA (Tib MoLBIOL GmbH, Berlin Germany). All HCV patients were genotyped as CC, CT or TT. Results: CT and TT variants were present in 45 and 18 subjects (56% and 23%, respectively) of the studied population. CC polymorphism had the lowest frequency in our cohort (21%, CI 95%: 12.89–31.83%) and it was strongly associated with response to standard treatment (OR 2.95); 76% of CC carriers achieved SVR compared with 55.5% and 44.4% of SVR in patients with CT and TT variants.
- Published
- 2011
- Full Text
- View/download PDF